Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Lupin Pharmaceuticals' (LPI) abbreviated new drug application (ANDA) for amlodipine / benazepril 5mg/40mg, and 10mg/40mg capsules.
Subscribe to our email newsletter
With this approval, the company has received approval for its complete product line of amlodipine / benazepril.
The US subsidiary of Lupin Limited, LPI’s amlodipine / benazepril capsules are the AB-rated generic equivalent to Lotrel capsules of Novartis, indiacted as a treatment of hypertension.
Lotrel contains a combination of amlodipine and benazepril.